Cell & Gene Therapy Review

🚀 We’re Live—Introducing Cell & Gene Therapy Review! We’re excited to announce the website launch of Cell & Gene Therapy Review, a dedicated resource for professionals in the cell and gene therapy field. Our new platform will bring together valuable insights, expert perspectives, and trusted resources to support the pharma manufacturing industry as it advances cutting-edge therapies. Stay tuned for the first issue of Cell & Gene Therapy Review, launching in early 2025! 🔗 https://lnkd.in/eRmMEFwt #CellAndGeneTherapy #PharmaManufacturing #GeneTherapy #CellTherapy #PharmaInnovation #Biopharma #AdvancedTherapies #RegenerativeMedicine #TherapeuticInnovation

CGT top 10 storylines As we head into a new year, it’s time to look back at 2024 and appreciate the tremendous progress made in cell and gene therapy Read the article by Mark Flower here - https://lnkd.in/gU4NZg4p #CellAndGeneTherapy #CancerTreatment #TILTherapy #Immunotherapy #BiotechInnovation #FDAApproval #PrecisionMedicine #ManufacturingInnovation #PharmaNews #HealthcareAdvancements

Studies find BHB supplement improves CAR-T cell function Read the news here - https://lnkd.in/gmsgnQY3 #CellTherapy #GeneTherapy #CARTCells #KetogenicDiet #BHBSupplement #CancerResearch #Immunotherapy #PennMedicine #Hematology

I am looking forward to an amazing 2025, and a new role as an Editorial Advisory Board Member at Cell & Gene Therapy Review. If you haven't yet discovered this source for #CellandGeneTherapy news I encourage you to take a look! https://lnkd.in/g8hT-ZnM

Announcing ARM's last Sector Snapshot of 2024! 🧬 📄 With 2024 nearing an end, the cell and gene therapy sector has witnessed another transformative year marked by groundbreaking advances and continued maturation. ARM’s December 2024 Sector Snapshot recaps this year's milestones that shaped the cell and gene therapy sector. Read the full publication here to see the milestones: ➡️ https://lnkd.in/e_SRS38z Over the next week, we’ll highlight each of these individual milestones. 

💫 As we close out this year and look ahead to new beginnings, we wish you joyful holidays and a bright year full of opportunities. Here's to growth, discovery, and exciting journeys ahead! 💫 #HappyHolidays #SeasonGreetings

We are thrilled to have Sanjin Zvonić as part of our growing editorial advisory board! In my previous role, Sanjin was always my go-to "phone a friend" on all things cell and gene. As a lifelong journalist who at times struggles with complex science, I have relied on the expertise of those around me to help me produce and share quality content. The old adage, "If you can't explain it simply, you don't understand it well enough" certainly rings true — and Sanjin has a knack for making the highly complex digestible (and sometimes even a little entertaining — CGT but add flair). Looking forward to working with Sanjin as we continue to build this new brand! -KL

In a recent Cell & Gene Therapy Review Article, Igor Fisch comments on Switzerland's growing role as a hub for cell and gene therapies. We're honored to be recognized in Switzerland for our contributions to advancing gene and cell therapy development. At NewBiologix, we're focused on improving scalable, cost-effective viral vector production to support the future of these transformative therapies. Learn more about Switzerland's emerging leadership in cell and gene therapies: http://bit.ly/3ZWW883 #CellTherapy #GeneTherapy #BiotechInnovation #NewBiologix

Editas slashes workforce, pivots toward in vivo gene editing Read the article here - https://lnkd.in/ghT4weHF #GeneEditing #CRISPR #InVivoTherapies #EditasMedicine #BiotechNews #SickleCellResearch #BetaThalassemia #BiotechInnovation #GeneTherapy

SpliceBio wins first FDA clearance for protein splicing gene therapy Read the news here - https://lnkd.in/gJ8p_Kb4 #SpliceBio #FDAApproval #INDClearance #GeneTherapy #StargardtDisease #MacularDegeneration #ProteinSplicing #ABCA4Gene #OrphanDrug #RareDiseases